Approvals/TGA/YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe in autoinjector

Approved

STANDARD

YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe in autoinjector

Celltrion Healthcare Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 2464000e89fd2192
Product Name: YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe in autoinjector
Artg Id: 367771
Artg Name: YUFLYMA adalimumab (rch) 40 mg/0.4 mL solution for injection pre-filled syringe in autoinjector
Sponsor: Celltrion Healthcare Australia Pty Ltd
Company Detail Path: /organization/celltrion-healthcare-australia-pty-ltd
Artg Date: 2022-03-25
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b4292b65f3e24b021a6a8c5f1ee6dc60.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/5cbd8e82d87d56c4941a83e652f6b216.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2464000e89fd2192

Type

Standard